Jiangxi Sanxin Medtec Co Ltd
SZSE:300453
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jiangxi Sanxin Medtec Co Ltd
Operating Income
Jiangxi Sanxin Medtec Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Jiangxi Sanxin Medtec Co Ltd
SZSE:300453
|
Operating Income
¥298m
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
|
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
Operating Income
¥610.4m
|
CAGR 3-Years
27%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Operating Income
¥1.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Operating Income
¥827.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Operating Income
¥2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Operating Income
¥991.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Jiangxi Sanxin Medtec Co Ltd
Glance View
Jiang Xi Sanxin Medtec Co., Ltd. engages in the research, development, manufacture, and sale of medical devices. The company is headquartered in Nanchang, Jiangxi and currently employs 1,879 full-time employees. The company went IPO on 2015-05-15. The firm's products include five series: syringe series, infusion & transfusion series, catheter tubing series, blood purification series and other series. The firm distributes its products within the domestic markets and to overseas markets.
See Also
What is Jiangxi Sanxin Medtec Co Ltd's Operating Income?
Operating Income
298m
CNY
Based on the financial report for Sep 30, 2025, Jiangxi Sanxin Medtec Co Ltd's Operating Income amounts to 298m CNY.
What is Jiangxi Sanxin Medtec Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
18%
Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Jiangxi Sanxin Medtec Co Ltd have been 9% over the past three years , 16% over the past five years , and 18% over the past ten years .
